\
&
Contact us
\
&
Contact us
Published on | 2 months ago
Programmes Horizon EuropeThe coming months it will become obligatory to secure your account on the Funding and Tenders Portal by adding a second authentication (apart from your password).
From 30 June 2025 onwards, the authentication method through SMS will be phased out completely so make sure to set up another verification method in time (e.g. Security Key, Trusted Platform, EU Login Mobile App).
You can consult the following resources to choose one of the methods: web page of the recent webinar of the Commission regarding Two-factor Authentication, manual and video tutorial in the IT Support Guide.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
